287 related articles for article (PubMed ID: 30569287)
1. Hinokitiol Offers Neuroprotection Against 6-OHDA-Induced Toxicity in SH-SY5Y Neuroblastoma Cells by Downregulating mRNA Expression of MAO/α-Synuclein/LRRK2/PARK7/PINK1/PTEN Genes.
Varier KM; Sumathi T
Neurotox Res; 2019 May; 35(4):945-954. PubMed ID: 30569287
[TBL] [Abstract][Full Text] [Related]
2. Anthraquinone from Edible Fungi Pleurotus ostreatus Protects Human SH-SY5Y Neuroblastoma Cells Against 6-Hydroxydopamine-Induced Cell Death-Preclinical Validation of Gene Knockout Possibilities of PARK7, PINK1, and SNCA1 Using CRISPR SpCas9.
J B; Das A; Sakthivel KM
Appl Biochem Biotechnol; 2020 Jun; 191(2):555-566. PubMed ID: 31820379
[TBL] [Abstract][Full Text] [Related]
3. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
4. Glycyrrhizic Acid Alleviates 6-Hydroxydopamine and Corticosterone-Induced Neurotoxicity in SH-SY5Y Cells Through Modulating Autophagy.
Yang G; Li J; Cai Y; Yang Z; Li R; Fu W
Neurochem Res; 2018 Oct; 43(10):1914-1926. PubMed ID: 30206804
[TBL] [Abstract][Full Text] [Related]
5. Maackiain Ameliorates 6-Hydroxydopamine and
Tsai RT; Tsai CW; Liu SP; Gao JX; Kuo YH; Chao PM; Hung HS; Shyu WC; Lin SZ; Fu RH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585871
[TBL] [Abstract][Full Text] [Related]
6. MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway.
Ge H; Yan Z; Zhu H; Zhao H
Exp Mol Pathol; 2019 Aug; 109():16-24. PubMed ID: 31067440
[TBL] [Abstract][Full Text] [Related]
7. Hesperidin downregulates kinases lrrk2 and gsk3β in a 6-OHDA induced Parkinson's disease model.
Kesh S; Kannan RR; Sivaji K; Balakrishnan A
Neurosci Lett; 2021 Jan; 740():135426. PubMed ID: 33075420
[TBL] [Abstract][Full Text] [Related]
8. 6-Hydroxydopamine induces secretion of PARK7/DJ-1 via autophagy-based unconventional secretory pathway.
Urano Y; Mori C; Fuji A; Konno K; Yamamoto T; Yashirogi S; Ando M; Saito Y; Noguchi N
Autophagy; 2018; 14(11):1943-1958. PubMed ID: 30112966
[TBL] [Abstract][Full Text] [Related]
9. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
[TBL] [Abstract][Full Text] [Related]
10. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H
Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
[TBL] [Abstract][Full Text] [Related]
11. DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70.
Batelli S; Albani D; Rametta R; Polito L; Prato F; Pesaresi M; Negro A; Forloni G
PLoS One; 2008 Apr; 3(4):e1884. PubMed ID: 18382667
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of α-synuclein.
Ho DH; Seol W; Son I
Cell Cycle; 2019 Feb; 18(4):467-475. PubMed ID: 30712480
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Effects of Tanshinone I Against 6-OHDA-Induced Oxidative Stress in Cellular and Mouse Model of Parkinson's Disease Through Upregulating Nrf2.
Jing X; Wei X; Ren M; Wang L; Zhang X; Lou H
Neurochem Res; 2016 Apr; 41(4):779-86. PubMed ID: 26537816
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Parkinson's disease-related proteins in mediating secondary brain damage after cerebral ischemia.
Kim T; Vemuganti R
J Cereb Blood Flow Metab; 2017 Jun; 37(6):1910-1926. PubMed ID: 28273718
[TBL] [Abstract][Full Text] [Related]
15. NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson's Disease.
Anantha J; Goulding SR; Tuboly E; O'Mahony AG; Moloney GM; Lomansey G; McCarthy CM; Collins LM; Sullivan AM; O'Keeffe GW
Mol Neurobiol; 2022 Jan; 59(1):61-76. PubMed ID: 34623600
[TBL] [Abstract][Full Text] [Related]
16. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
[TBL] [Abstract][Full Text] [Related]
17. DJ-1-Mediated protective effect of protocatechuic aldehyde against oxidative stress in SH-SY5Y cells.
Gao JW; Yamane T; Maita H; Ishikawa S; Iguchi-Ariga SM; Pu XP; Ariga H
J Pharmacol Sci; 2011; 115(1):36-44. PubMed ID: 21160133
[TBL] [Abstract][Full Text] [Related]
18. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.
Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579
[TBL] [Abstract][Full Text] [Related]
19. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.
Lopes FM; Schröder R; da Frota ML; Zanotto-Filho A; Müller CB; Pires AS; Meurer RT; Colpo GD; Gelain DP; Kapczinski F; Moreira JC; Fernandes Mda C; Klamt F
Brain Res; 2010 Jun; 1337():85-94. PubMed ID: 20380819
[TBL] [Abstract][Full Text] [Related]
20. Disease model organism for Parkinson disease: Drosophila melanogaster.
Aryal B; Lee Y
BMB Rep; 2019 Apr; 52(4):250-258. PubMed ID: 30545438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
